Filing Flows › Verastem (VSTM) › Recalls, complaints & regulation
Verastem (VSTM): clinical trials
Verastem (VSTM) beyond its filings: 10 active clinical trials.
Verastem's latest quarter
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Verastem have?
10 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.